Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
VIVUS LLC
Age
30–60
Sex
MALE
Healthy volunteers
Accepted
You may be eligible if
Provide written informed consent
Willing to comply with all study requirements and clinic schedules
Male between 30 to 60 years of age
Non-smoker
No history of alcohol abuse
Normal screening laboratory values
You may not be if
Allergy or hypersensitive to PDE5 inhibitors
Evidence of clinically significant disease
Supine systolic/diastolic blood pressure level
History of cardiovascular disease
Previously participated in TA-1790 within the past 30 days
Clareo Health | Study to Evaluate Hemodynamic Response to to a Sublingual Dose of Glyceryl Trinitrate in Subjects Receiving TA-1790, Sildenafil Citrate, and Placebo
